FINWIRES · TerminalLIVE
FINWIRES

Italy's UniCredit Set to Divest Part of Russian Unit to UAE Investor

作者

-- UniCredit (UCG.MI) reached a nonbinding deal to sell part of its Russian subsidiary to a "well-established private investor" in the United Arab Emirates, as part of plans to refocus its operations in Russia around international payments.

Under the terms of the potential transaction, the Italian banking group intends to spin off part of AO Bank's activities into a new separate entity, which UniCredit would fully own, according to a Thursday release. Meanwhile, the remaining operations would be sold to the unspecified buyer, who has "long standing ties to the local institutional and business community" in the UAE.

UniCredit expects the divestment to result in a cumulative negative impact of between 3 billion euros and 3.3 billion euros on its net income. However, the bank noted that this will not affect its shareholder distribution or its net profit targets for the 2028 to 2030 period.

The group added that the deal is anticipated to boost its overall capital position with a 35 basis-point improvement.

"The transition has been structured and shall be executed to ensure continuity and stability for clients and employees. Customers utilizing UniCredit's payment solutions to and from Russia will maintain access to the current set of operations throughout the process," the group said.

UniCredit noted that both parties will work together to finalize the structure of the planned divestment. The deal is expected to close in the first half of 2027, subject to both parties reaching a binding agreement, the implementation of the spin-off of part of AO Bank's activities, and relevant regulatory approvals. 

相關文章

Asia

時代中國控股4月合約銷售額達3.2億元人民幣

時代中國控股有限公司(港交所代號:1233)4月成交額為3.2億元人民幣,成交建築面積為39,700平方公尺。 該公司週四在香港提交的公告顯示,截至4月30日的四個月內,成交額和成交建築面積分別達到12億元人民幣和125,600平方公尺。

$HKG:1233
Asia

虎娃製藥的止咳顆粒劑贏得中藥採購項目競標

根據海南虎露娃藥業(SHA:605199)週四向上海證券交易所提交的文件顯示,該公司生產的兒童肺熱止咳顆粒劑成功中標中國傳統藥品採購計畫。 此顆粒劑有助於改善肺功能,並可用於治療感冒、支氣管炎、支氣管肺炎等疾病。

$SHA:605199
Asia

長瀨株式會社2025財年獲利預估成長30%

長瀨株式會社(東京證券交易所代碼:8012)2025財年歸屬於母公司股東的淨利潤較上年同期增長近30%,達到331億日元,而上年同期為255億日元。 該公司週四向東京證券交易所提交的文件顯示,其基本每股收益從去年同期的57.60日圓增至78.89日圓。 截至3月31日的財年,淨銷售額成長2.9%,達到9,728億日元,而上年同期約為9,450億日圓。 該公司宣布派發末期股息,每股55日元,將於6月18日起發放。 該公司預計2026財年歸屬於股東的淨利為345億日元,每股收益為84.59日元,淨銷售額為1兆日圓。 永瀨計畫派發本年度中期股息和年末股息,每股分別為 13 日圓和 14 日圓,高於去年同期派發的股利金額。

$TYO:8012